Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Peichan Zheng

Fujian Center for Safety Evaluation of New Drug, Fujian Medical University, Fuzhou, China

Biography

Dr. Peichan Zheng is a well-known author and researcher in the field of Cancer research, working at the Fujian Center for Safety Evaluation of New Drug in Fujian Medical University, China.
Publications

BTG1 Low Expression in Pancreatic Ductal Adenocarcinoma is Associated with a Poorer Prognosis

Objective: BTG1 is a member of the TOB/BTG protein family, which is a transducer of ErbB-2 and TOB2. BTG1 is known to inhibit tumor genesis, but the role of it in pancreatic ductal adenocarcinoma is still unknown. The purpose of this study is to investigate the expression of BTG1 protein in pancreatic ductal adenocarcinoma (PDAC) and to determine i... Read More»

Yufang Huang, Jiawei Zheng, Ting Tan, Li Song, Shanshan Huang, Yan Zhang, Lin Lin, Jingnan Liu, Peichan Zheng, Xiong Chen, Xi Chen and Xuenong Ouyang

Research Article: Diagn Pathol Open 2017, 1: 126

DOI: 10.4172/2476-2024.1000126

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Global Speakers in the subject

Global Experts in the subject

Top